Using multiple cytokines to predict hepatocellular carcinoma recurrence in two patient cohorts
Rong Guo(Sun Yat-sen University), Chong Zhong(Guangzhou University of Chinese Medicine), Wei Wei(Zhujiang Hospital), Z-X Guo(Sun Yat-sen University), C-Z Xiao(Sun Yat-sen University), SH Li(Shanghai Jiao Tong University), Minqi Shi(Sun Yat-sen University), C-N Qian(Sun Yat-sen University), L-X Peng(Sun Yat-sen University)
Cited by 23
Related Papers
Sorafenib Plus Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, and Leucovorin vs Sorafenib Alone for Hepatocellular Carcinoma With Portal Vein Invasion
|JAMA Oncology|2019|559
Camrelizumab Plus Apatinib in Patients With Advanced Cervical Cancer (CLAP): A Multicenter, Open-Label, Single-Arm, Phase II Trial
|Journal of Clinical Oncology|2020|217
Lenvatinib, toripalimab, plus hepatic arterial infusion chemotherapy <i>versus</i> lenvatinib alone for advanced hepatocellular carcinoma
|Therapeutic Advances in Medical Oncology|2021|216
A clinical study on the short-term effect of berberine in comparison to metformin on the metabolic characteristics of women with polycystic ovary syndrome
|European Journal of Endocrinology|2011|160